St. Jude Medical, Inc.

Enrollment begun in study of relationship atrial high rate episodes and stroke

Published in Elder Law Weekly, March 23rd, 2005

St. Jude Medical, Inc. (STJ) announced enrollment of the first patients in the ASSERT ("ASymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial") clinical study.

The study will follow 2,500 patients for 3-1/2 years to determine if pacemaker-detected AHRE (atrial high rate events) predict an increased risk of stroke in elderly hypertensive patients without previous atrial fibrillation (AF). ASSERT also examines the efficacy of St. Jude Medical's AF suppression algorithm in helping these patients avoid symptomatic AF.

Sinan Gursoy, MD, enrolled the first U.S. patient in the ASSERT study at Naples Community...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Elder Law Weekly

Source: Elder Law Weekly (2005-03-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry